nach oben

Clinical Rheumatology

Erschienen in:

27.02.2020 | Brief Report

The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort

verfasst von: Youssef Roman, Maarit Tiirikainen, Elizabeth Prom-Wormley

Erschienen in: Clinical Rheumatology | Ausgabe 8/2020

Einloggen, um Zugang zu erhalten

Abstract

Gout is a metabolic disorder and one of the most common arthritic conditions. Hyperuricemia is the hallmark of developing gout and mostly caused by uric acid underexcretion. Gout disproportionately affects people of specific races and ethnicities. Filipinos are the second-largest Asian population in the USA and reported to have a higher prevalence of gout and hyperuricemia than non-Filipino counterparts and Filipinos residing in the Philippines. The genetic polymorphism rs2231142 G>T in the ABCG2 has been strongly associated with hyperuricemia and gout across multiple populations. However, the prevalence of this variant in Filipinos is unknown. Therefore, assessing the prevalence of this variant may provide insights on the high prevalence of hyperuricemia and gout in Filipinos. A total of 190 DNA samples from pregnant females who self-identified as a Filipino from the Hawaii Biorepository Bank were genotyped for rs2231142 G>T in the ABCG2. The prevalence of the gout risk allele (T) (46%) was significantly higher in Filipinos than in samples of Caucasians (12%, p < 0.001), Han Chinese (29%, p = 0.014), and African Americans (3%, p < 0.001). Similarly, the prevalence of the gout-risk genotype (TT) (21%) was significantly higher in Filipinos than in samples of Caucasians (1%, p < 0.001), Han Chinese (9%, p = 0.002), and African Americans (0.1%, p < 0.001). Though there were no gout cases in this cohort, these findings are suggestive of a genetic basis to the high prevalence of hyperuricemia and gout in Filipinos. This might also explain the reported reduced urinary uric acid excretion in Filipinos compared with Caucasians.

Key Points

• The Filipinos have the highest prevalence of the gout-associated risk allele (T) of the rs2231142 G>T in ABCG2.

• The high prevalence of the risk allele (T) of the rs2231142 G>T in ABCG2 may partly explain the reduced urinary urate excretion and early-onset gout in Filipinos.

• The high prevalence of the risk allele (T) of the rs2231142 G > T in ABCG2 may predispose Filipinos to hyperuricemia and gout when acculturated to high-purine diet.

Zhu Y, Pandya BJ, Choi HK (2011) Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 63(10):3136–3141. https://doi.org/10.1002/art.30520CrossRefPubMed

Choi HK, Mount DB, Reginato AM, American College of P, American Physiological S (2005) Pathogenesis of gout. Ann Intern Med 143(7):499–516. https://doi.org/10.7326/0003-4819-143-7-200510040-00009CrossRefPubMed

Krishnan E (2012) Reduced glomerular function and prevalence of gout: NHANES 2009-10. PLoS One 7(11):e50046. https://doi.org/10.1371/journal.pone.0050046CrossRefPubMedPubMedCentral

Kuo CF, Grainge MJ, Zhang W, Doherty M (2015) Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 11(11):649–662. https://doi.org/10.1038/nrrheum.2015.91CrossRefPubMed

Roddy E, Choi HK (2014) Epidemiology of gout. Rheum Dis Clin N Am 40(2):155–175. https://doi.org/10.1016/j.rdc.2014.01.001CrossRef

Roman YM (2019) The Daniel K. Inouye College of Pharmacy Scripts: perspectives on the epidemiology of gout and hyperuricemia. Hawaii J Med Public Health 78(2):71–76PubMedPubMedCentral

Winnard D, Wright C, Taylor WJ, Jackson G, Te Karu L, Gow PJ, Arroll B, Thornley S, Gribben B, Dalbeth N (2012) National prevalence of gout derived from administrative health data in Aotearoa New Zealand. Rheumatology (Oxford) 51(5):901–909. https://doi.org/10.1093/rheumatology/ker361CrossRef

Hoeffel EM, Rastogi S, Kim MO, Hasan S (2012) The asian population: 2010. US Department of Commerce, Economics and Statistics Administration, US

Bayani-Sioson PS, Healey LA Jr, Decker JL (1966) Are Filipinos hyperuricemia? Acta Med Philipp 2(4):206–207PubMed

10.

Torralba TP, Bayani-Sioson PS (1975) The Filipino and gout. Semin Arthritis Rheum 4(4):307–320. https://doi.org/10.1016/0049-0172(75)90015-3CrossRefPubMed

11.

Prasad P, Krishnan E (2014) Filipino gout: a review. Arthritis Care Res 66(3):337–343. https://doi.org/10.1002/acr.22118CrossRef

12.

Duff IF, Mikkelsen WM, Dodge HJ, Himes DS (1968) Comparison of uric acid levels in some Oriental and Caucasian groups unselected as to gout or hyperuricemia. Arthritis Rheum: Official Journal of the American College of Rheumatology 11(2):184–190. https://doi.org/10.1002/art.1780110209CrossRef

13.

Healey LA, Skeith MD, Decker JL, Bayani-Sioson PS (1967) Hyperuricemia in Filipinos: interaction of heredity and environment. Am J Hum Genet 19(2):81–85PubMedPubMedCentral

14.

Healey LA, Bayani-Sioson PS (1971) A defect in the renal excretion of uric acid in Filipinos. Arthritis Rheum 14(6):721–726. https://doi.org/10.1002/art.1780140606CrossRefPubMed

15.

Shai A, Rimar D, Rozenbaum M, Wolfovitz E, Rosner I (2010) Gout in young migrant Filipino women in Israel: a changing epidemiology. Case reports and review of the literature. Rheumatol Int 30(12):1685–1687. https://doi.org/10.1007/s00296-009-1198-7CrossRefPubMed

16.

Matsuo H, Nakayama A, Sakiyama M, Chiba T, Shimizu S, Kawamura Y, Nakashima H, Nakamura T, Takada Y, Oikawa Y, Takada T, Nakaoka H, Abe J, Inoue H, Wakai K, Kawai S, Guang Y, Nakagawa H, Ito T, Niwa K, Yamamoto K, Sakurai Y, Suzuki H, Hosoya T, Ichida K, Shimizu T, Shinomiya N (2014) ABCG2 dysfunction causes hyperuricemia due to both renal urate underexcretion and renal urate overload. Sci Rep 4:3755. https://doi.org/10.1038/srep03755CrossRefPubMedPubMedCentral

17.

Kannangara DR, Phipps-Green AJ, Dalbeth N, Stamp LK, Williams KM, Graham GG, Day RO, Merriman TR (2016) Hyperuricaemia: contributions of urate transporter ABCG2 and the fractional renal clearance of urate. Ann Rheum Dis 75(7):1363–1366. https://doi.org/10.1136/annrheumdis-2015-208111CrossRefPubMed

18.

Zhang K, Li C (2019) ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population. Hereditas 156:26. https://doi.org/10.1186/s41065-019-0103-yCrossRefPubMedPubMedCentral

19.

Cheng ST, Wu S, Su CW, Teng MS, Hsu LA, Ko YL (2017) Association of ABCG2 rs2231142-A allele and serum uric acid levels in male and obese individuals in a Han Taiwanese population. J Formos Med Assoc 116(1):18–23. https://doi.org/10.1016/j.jfma.2015.12.002CrossRefPubMed

20.

Zhang L, Spencer KL, Voruganti VS, Jorgensen NW, Fornage M, Best LG, Brown-Gentry KD, Cole SA, Crawford DC, Deelman E, Franceschini N, Gaffo AL, Glenn KR, Heiss G, Jenny NS, Kottgen A, Li Q, Liu K, Matise TC, North KE, Umans JG, Kao WH (2013) Association of functional polymorphism rs2231142 (Q141K) in the ABCG2 gene with serum uric acid and gout in 4 US populations: the PAGE study. Am J Epidemiol 177(9):923–932. https://doi.org/10.1093/aje/kws330CrossRefPubMedPubMedCentral

21.

Chen CJ, Tseng CC, Yen JH, Chang JG, Chou WC, Chu HW, Chang SJ, Liao WT (2018) ABCG2 contributes to the development of gout and hyperuricemia in a genome-wide association study. Sci Rep 8(1):3137. https://doi.org/10.1038/s41598-018-21425-7CrossRefPubMedPubMedCentral

22.

Zaidi F, Narang RK, Phipps-Green A, Gamble GG, Tausche AK, So A, Riches P, Andres M, Perez-Ruiz F, Doherty M, Janssen M, Joosten LAB, Jansen TL, Kurreeman F, Torres RJ, McCarthy GM, Miner JN, Stamp LK, Merriman TR, Dalbeth N (2020) Systematic genetic analysis of early-onset gout: ABCG2 is the only associated locus. Rheumatology (Oxford). https://doi.org/10.1093/rheumatology/kez685

23.

Roman YM, Culhane-Pera KA, Menk J, Straka RJ (2016) Assessment of genetic polymorphisms associated with hyperuricemia or gout in the Hmong. Perinat Med 13(5):429–440. https://doi.org/10.2217/pme-2016-0021CrossRef

24.

Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, Mangino M, Albrecht E, Wallace C, Farrall M, Johansson A, Nyholt DR, Aulchenko Y, Beckmann JS, Bergmann S, Bochud M, Brown M, Campbell H, Consortium E, Connell J, Dominiczak A, Homuth G, Lamina C, McCarthy MI, Consortium E, Meitinger T, Mooser V, Munroe P, Nauck M, Peden J, Prokisch H, Salo P, Salomaa V, Samani NJ, Schlessinger D, Uda M, Volker U, Waeber G, Waterworth D, Wang-Sattler R, Wright AF, Adamski J, Whitfield JB, Gyllensten U, Wilson JF, Rudan I, Pramstaller P, Watkins H, Consortium P, Doering A, Wichmann HE, Study K, Spector TD, Peltonen L, Volzke H, Nagaraja R, Vollenweider P, Caulfield M, Wtccc IT, Gieger C (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5(6):e1000504. https://doi.org/10.1371/journal.pgen.1000504CrossRefPubMedPubMedCentral

25.

Kuo CF, Grainge MJ, See LC, Yu KH, Luo SF, Zhang W, Doherty M (2015) Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther 17:13. https://doi.org/10.1186/s13075-015-0522-8CrossRefPubMedPubMedCentral

26.

Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T, Kawamura Y, Takada Y, Yamamoto K, Inoue H, Oikawa Y, Naito M, Hishida A, Wakai K, Okada C, Shimizu S, Sakiyama M, Chiba T, Ogata H, Niwa K, Hosoyamada M, Mori A, Hamajima N, Suzuki H, Kanai Y, Sakurai Y, Hosoya T, Shimizu T, Shinomiya N (2013) Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep 3:2014. https://doi.org/10.1038/srep02014CrossRefPubMedPubMedCentral

27.

Culhane-Pera KA, Straka RJ, Moua M, Roman YM, Vue P, Xiaaj K, Lo MX, Lor M (2017) Engaging Hmong adults in genomic and pharmacogenomic research: toward reducing health disparities in genomic knowledge using a community-based participatory research approach. J Commun Gen 8(2):1–9. https://doi.org/10.1007/s12687-017-0292-xCrossRef

28.

Roman YM (2019) Race and precision medicine: is it time for an upgrade? Pharm J 19(1):1–4. https://doi.org/10.1038/s41397-018-0046-0CrossRef

Titel: The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort
verfasst von: Youssef Roman
Maarit Tiirikainen
Elizabeth Prom-Wormley
Publikationsdatum: 27.02.2020
Verlag: Springer International Publishing
Erschienen in: Clinical Rheumatology / Ausgabe 8/2020
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-04994-9

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2020

Correction to: Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study

Comment on “Colchicine may not be effective in COVID-19 infection; it may even be harmful?”

Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis

COVID-19 and Kawasaki disease: an analysis using Google Trends

Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty

Fatigue and contributing factors in Chinese patients with ankylosing spondylitis

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

15% bedauern gewählte Blasenkrebs-Therapie

Costims – das nächste heiße Ding in der Krebstherapie?

Update Innere Medizin